SNNStock
Verdicts genuinely change. Free email alert the moment SNN's does — no target price to set, unlike "Alert" above.
Whether this company clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Trade plan
Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.
SNN is currently considered not halal (non-compliant), per In-house ratio engine. See the full ratio breakdown and business-activity screen below for the reasoning.
⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.
454 other Healthcare stocks pass this same screen. See compliant Healthcare stocks →
🕌 In-house Compliance Research
Computed from published company financials, balance sheet as of 2025-12-31. SNN files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.
Business activity: cleared (no excluded categories detected)
AAOIFI Fail
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 34.93% | 30.00% | Fail |
| Interest-bearing investments | 6.25% | 30.00% | Pass |
| Non-permissible income | 0.00% | 5.00% | Pass |
Usmani Pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 29.75% | 33.00% | Pass |
| Interest-bearing investments | 5.33% | 33.00% | Pass |
| Non-liquid assets | 81.16% | at least 20.00% | Pass |
| Non-permissible income | 0.00% | 5.00% | Pass |
MSCI Pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 29.75% | 33.33% | Pass |
| Cash + interest-bearing securities | 5.33% | 33.33% | Pass |
| Accounts receivable | 18.84% | 33.33% | Pass |
| Non-permissible income | 0.00% | 5.00% | Pass |
FTSE Pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 29.75% | 33.33% | Pass |
| Cash + interest-bearing securities | 5.33% | 33.33% | Pass |
| Accounts receivable | 18.84% | 50.00% | Pass |
| Non-permissible income | 0.00% | 5.00% | Pass |
Dow Jones Islamic Market Pass
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 31.70% | 33.00% | Pass |
| Cash + interest-bearing securities | 5.68% | 33.00% | Pass |
| Accounts receivable | 14.40% | 33.00% | Pass |
| Non-permissible income | 0.00% | 5.00% | Pass |
S&P Shariah Fail
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 33.49% | 33.00% | Fail |
| Cash + interest-bearing securities | 6.00% | 49.00% | Pass |
| Accounts receivable | 15.21% | 49.00% | Pass |
| Non-permissible income | 0.00% | 5.00% | Pass |
MSCI M-Series Fail
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 33.49% | 33.33% | Fail |
| Cash + interest-bearing securities | 6.00% | 33.33% | Pass |
| Accounts receivable | 21.21% | 49.00% | Pass |
| Non-permissible income | 0.00% | 5.00% | Pass |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
How close is it to flipping?
Every current reading against its own line, closest first. A verdict is only as durable as that distance.
The numbers the ratios are built from
Read from SNN's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.
| Line | Figure | As reported | Read from |
|---|---|---|---|
| RevenueTotal revenue for the period | $6.2B | 2025-12-31 | RevenueFromContractsWithCustomers |
| Interest-bearing debtShort and long-term borrowings | $3.1B | 2025-12-31 | Borrowings |
| Cash and interest-bearing securitiesCash, equivalents and marketable securities | $557.0M | 2025-12-31 | CashAndCashEquivalents |
| Total assetsBalance sheet total | $10.5B | 2025-12-31 | Assets |
| Market capDenominator for AAOIFI | $8.9B | live quote | price x shares |
| 36-month average market capDenominator for S&P Shariah and MSCI M-Series | $24.9B | 756 trading days | closes x shares |
| 24-month average market capDenominator for Dow Jones Islamic Market | $26.4B | 504 trading days | closes x shares |
| Non-permissible revenueInterest and excluded income | $0 | 2025-12-31 | no interest-income tag reported in 3+ years (treated as $0) |
Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.
What changed, and when
Verdict history for SNN. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
- 2026-09-07 No change recorded No verdict change for SNN has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.
Tracked since 2026-09-07.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Ray Dalio | Bridgewater Associates | $8M | 0.0% | 2026-06-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 43.10 | NEUTRAL |
| Stochastic %K (14) | 49.99 | NEUTRAL |
| CCI (20) | -38.29 | NEUTRAL |
| Williams %R (14) | -50.01 | NEUTRAL |
| MACD (12,26,9) | 0.04 | BUY |
| ROC (10) | -1.63 | SELL |
| Momentum (10) | -0.44 | SELL |
| EMA (10) | 26.75 | BUY |
| SMA (10) | 26.63 | BUY |
| EMA (20) | 27.14 | SELL |
| SMA (20) | 27.05 | SELL |
| EMA (30) | 27.53 | SELL |
| SMA (30) | 27.59 | SELL |
| EMA (50) | 28.14 | SELL |
| SMA (50) | 28.62 | SELL |
| EMA (100) | 29.15 | SELL |
| SMA (100) | 29.25 | SELL |
| EMA (200) | 30.67 | SELL |
| SMA (200) | 30.93 | SELL |
About SNN
Healthcare · Medical Devices
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Background via Yahoo Finance — informational, not part of the verdict.
Latest Signal — 2026-10-05
Stop 26.07 Now 26.92 Target 27.99
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is this a fatwa?
No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.
Why can the standards disagree?
Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.
How often is this re-screened?
Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.
Do I need to purify dividends?
If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Still fetching insider filings — it ran past this page's budget, so the page painted without waiting. The fetch is still running; reload in a moment and it will be here.
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-09-29 · Asset managers net 904003 (-30452)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.